do not combine glp-1 receptor agonists with dpp-4 inhibitors guideline Clinical Use of Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)

These benefits were achieved without serious adverse effects, and GLP-1 RA use was associated with reduced reliance on acetazolamide and avoidance of surgical interventions

The cardioprotective effects of GLP-1 RAs along with their low risk of hypoglycemia make them preferred agents in any multidisciplinary approach for prevention of CVDs, reduction of the disease burden and improvement of prognosis

[DOI] [PubMed] [Google Scholar] 137.Li CJ, Li J, Zhang QM, Lv L, Chen R, Lv CF, Yu P, Yu DM

Modification of the coupling and loss of beta-adrenergic receptors

The sensitivity analysis excluding one trial with a short duration and one trial that recruited participants on background insulin therapy yielded similar results and reduced statistical heterogeneity

That refers to other health problems, such as diabetes, asthma or high blood pressure